Literature DB >> 6947217

Expression of early adenovirus genes requires a viral encoded acidic polypeptide.

R P Ricciardi, R L Jones, C L Cepko, P A Sharp, B E Roberts.   

Abstract

Host-range mutants of adenovirus 5 that contain a defect in region E1A (0-4.5 units) fail to replicate in HeLa cells and to transform rodent cells. In HeLa cells, these mutants synthesize only the two RNAs from E1A that share the same 5' and 3' termini but differ in length by the amount of internal sequence removed by splicing. RNA from wild-type virus, selected by hybridization to DNA from region E1A, translates into polypeptides of Mr 51,000 and 48,000 that are highly acidic in isoelectric focusing gels. These acidic Mr 51,000 and Mr 48,000 polypeptides are encoded by the longer and shorter E1A RNAs, respectively. Two of the host-range mutants, H5hr1 and H5hr2, fail to synthesize the Mr 51,000 polypeptide but do produce the Mr 48,000 polypeptide and a novel polypeptide thought to be a truncated portion of the Mr 51,000 polypeptide. H5hr1 and H5hr2 are hypothesized to have termination codons in sequences found only in RNA encoding the Mr 51,000 polypeptide. This prediction is verified for H5hr1 by DNA sequence analysis. The other three host-range mutants (H5hr3-5) synthesize both acidic polypeptides and are predicted to be missense. These results strongly imply that the Mr 51,000 polypeptide, alone or in combination with the Mr 48,000 polypeptide, is needed to regulate expression of adjacent viral genes during the early phase of adenovirus infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6947217      PMCID: PMC348989          DOI: 10.1073/pnas.78.10.6121

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Viral nucleic acid sequences in transformed cells. IV. A study of the sequences of adenovirus 5 DNA and RNA in four lines of adenovirus 5-transformed rodent cells using specific fragments of the viral genome.

Authors:  S J Flint; J Sambrook; J F Williams; P A Sharp
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

3.  Ultraviolet mapping of the adenovirus 2 early promoters.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

4.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

5.  Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride.

Authors:  J F Williams
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

6.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

7.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

8.  Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue.

Authors:  E Frost; J Williams
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

9.  Regulation of the galactose pathway in Saccharomyces cerevisiae: induction of uridyl transferase mRNA and dependency on GAL4 gene function.

Authors:  J E Hopper; J R Broach; L B Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

10.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  119 in total

1.  Adenovirus infection of differentiated F9 cells results in a global shut-off of differentiation-induced gene expression.

Authors:  R J Weigel; J R Nevins
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  The cellular transcription factor E2f requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expression.

Authors:  L E Babiss
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Limited temperature-sensitive transactivation by mutant adenovirus type 2 E1a proteins.

Authors:  M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Readthrough activation of early adenovirus E1b gene transcription.

Authors:  L F Maxfield; D J Spector
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator.

Authors:  D M Becker; S M Hollenberg; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression.

Authors:  B E Roberts; J S Miller; D Kimelman; C L Cepko; I R Lemischka; R C Mulligan
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

9.  Synthesis in Escherichia coli of human adenovirus type 12 transforming proteins encoded by early region 1A 13S mRNA and 12S mRNA.

Authors:  D Kimelman; L A Lucher; K H Brackmann; J S Symington; M Ptashne; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli.

Authors:  L A Lucher; D Kimelman; J S Symington; K H Brackmann; M A Cartas; H Thornton; M Green
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.